Deutsche Bank's £2m Positive Impact

Based on Deutsche Bank’s current national charity partnership - an additional funding injection of £2m+ over two years for Cure Leukaemia would be distributed in two key areas.

Click on the link below to read our application to Deutsche Bank to read more about these key areas...

All funds raised by Deutsche Bank will directly benefit patients battling blood cancer, just like 40-year-old firefighter Adam Joyce. Adam was first diagnosed with leukaemia in 2000 and was given just 3 months to live. Following treatment by Cure Leukaemia co-founder Professor Charlie Craddock, Adam's illness went in to remission and he was able to live a normal life once again.

 

He said, "I'm only here because of people like Professor Charlie Craddock and charities like Cure Leukaemia. I encourage Deutsche Bank staff to use one of their two votes to vote for Cure Leukaemia so that many more people can hear the three amazing words I heard all those years ago, you are cured." 

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell